Medpace Holdings, Inc. (MEDP)
NASDAQ
Real-time Data
01:30 PM
Day's Range
590.4652 wk Range
373.00Overview - MEDP - Medpace Holdings, Inc.
Key Statistics
Valuation
Enterprise Value
16.46B
P/E (Trailing)
‪35.48‬
P/E (Forward)
‪31.27‬
PEG Ratio
‪0.97‬
Price / Sales (TTM)
‪6.06‬
Price / Book
‪38.87‬
EV / EBITDA
‪26.94‬
Profitability
Gross Margin
‪28.50%‬
Profit Margin
‪17.66%‬
Operating Margin
‪20.75%‬
Return on Assets
‪20.09%‬
Return on Equity
‪162.15%‬
Ownership
Shares Outstanding
27.91M
Float
22.65M
Short % of Shares Outstanding
‪7.53%‬
Held by Insiders
‪18.73%‬
Held by Institutions
‪91.15%‬
Price stats
Beta
‪1.18‬
50-Day Avg
‪600.79‬
200-Day Avg
‪524.35‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 581.83‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MEDP - Medpace Holdings, Inc.
Peers - MEDP - Medpace Holdings, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
- TWSTNASDAQTwist Bioscience Corporation12.12BMarket Cap+85.23%52-week change-140.79P/E (Trailing)‪-31.66%‬Profit Margin
Profile Summary - MEDP - Medpace Holdings, Inc.
About
Medpace Holdings, Inc. is a global clinical research organization that provides outsourced clinical development services for biotechnology, pharmaceutical, and medical device companies. Medpace supports the full clinical trial lifecycle, from Phase I through Phase IV, with services that include study design, project…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
